| Issuer | % of Class | Filed |
|---|---|---|
|
Pelthos Therapeutics Inc.
13D/A
Amendment 2
PTHS · 171126204
|
49.9% |
11/3/2026
Event 10/30/2026
|
|
Xoma Royalty Corporation
13D
XOMA · 98419J206
|
47.0% |
5/1/2026
Event 4/27/2026
|
|
Pelthos Therapeutics Inc.
13D/A
Amendment 1
PTHS · 171126204
|
49.9% |
11/10/2025
Event 11/6/2025
|
|
Pelthos Therapeutics Inc.
13D
PTHS · 171126204
|
49.9% |
7/3/2025
Event 7/1/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.